Clinical Laserthermia Systems AB (publ) (CLS-B) — Capital Reinvestment Ratio

Latest as of December 2017: 1.75x

Clinical Laserthermia Systems AB (publ) (CLS-B) has a Capital Reinvestment Ratio of 1.75x as of December 2017, meaning it reinvests 2% of its operating cash flow (Skr372.00K) in capital expenditures (Skr652.55K). See CLS-B free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.75x

Capex / Operating Cash Flow

Operating Cash Flow

Skr372.00K

SEK

Capital Expenditures

Skr652.55K

SEK

Data as of

Dec 2017

Most recent filing

Annual Capital Reinvestment Ratio for Clinical Laserthermia Systems AB (publ) (None–None)

Year-by-year Capital Reinvestment Ratio for Clinical Laserthermia Systems AB (publ) from None to None. For live market cap and broader valuation context, see CLS-B company net worth.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow